Skip to Main Content

Peter Tebben, MD

Endocrinology, Pediatric Endocrinology & Diabetes
Telehealth is available
Learn more about telehealth
Patient type treated
Child, Adult
Accepting new patients
Yes
Referral required
Not Applicable

Biography

Peter Tebben, MD, is an endocrinologist who specializes in caring for children and adults with a range of hormonal and metabolic bone conditions, including growth disorders, diabetes, and rare bone diseases.

As an associate professor of medicine at Yale School of Medicine and director of the Yale Bone Center, Dr. Tebben supports research on bone metabolism and leads collaborative efforts to improve patient outcomes. “There is considerable need in the rare disease community. It is an exciting space to be a part of because of the development of better treatments that offer hope to people with rare bone disorders,” he says.

Dr. Tebben also highlights the importance of identifying and treating osteoporosis, noting that “because osteoporosis is a silent condition until a fracture occurs, those with high fracture risk often go unrecognized.” Part of his mission is to continue the development of a fracture liaison service to minimize the risk of future fractures. “Much of our effort needs to be focused on identifying patients who have the highest risk of fracture so we can address and minimize that risk with medications and other interventions,” he explains.

Dr. Tebben completed his medical training at the University of Kansas, followed by a combined residency in internal medicine and pediatrics at the University of Minnesota. He then pursued fellowships in adult and pediatric endocrinology at the Mayo Clinic.

Education & Training

  • Fellow
    Mayo Clinic (2006)
  • Fellow
    Mayo Clinic (2004)
  • Resident
    University of Minnesota (2002)
  • MD
    University of Kansas (1998)
  • BS
    University of Kansas (1994)
  • BS
    Kansas State University (1991)

Additional Information

Biography

Peter Tebben, MD, is an endocrinologist who specializes in caring for children and adults with a range of hormonal and metabolic bone conditions, including growth disorders, diabetes, and rare bone diseases.

As an associate professor of medicine at Yale School of Medicine and director of the Yale Bone Center, Dr. Tebben supports research on bone metabolism and leads collaborative efforts to improve patient outcomes. “There is considerable need in the rare disease community. It is an exciting space to be a part of because of the development of better treatments that offer hope to people with rare bone disorders,” he says.

Dr. Tebben also highlights the importance of identifying and treating osteoporosis, noting that “because osteoporosis is a silent condition until a fracture occurs, those with high fracture risk often go unrecognized.” Part of his mission is to continue the development of a fracture liaison service to minimize the risk of future fractures. “Much of our effort needs to be focused on identifying patients who have the highest risk of fracture so we can address and minimize that risk with medications and other interventions,” he explains.

Dr. Tebben completed his medical training at the University of Kansas, followed by a combined residency in internal medicine and pediatrics at the University of Minnesota. He then pursued fellowships in adult and pediatric endocrinology at the Mayo Clinic.

Education & Training

  • Fellow
    Mayo Clinic (2006)
  • Fellow
    Mayo Clinic (2004)
  • Resident
    University of Minnesota (2002)
  • MD
    University of Kansas (1998)
  • BS
    University of Kansas (1994)
  • BS
    Kansas State University (1991)

Additional Information